Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.22 - $0.66 $1,834 - $5,503
-8,339 Reduced 24.36%
25,887 $10,000
Q3 2023

Nov 14, 2023

SELL
$0.2 - $1.78 $3,474 - $30,922
-17,372 Reduced 33.67%
34,226 $7,000
Q2 2023

Aug 21, 2023

SELL
$1.02 - $1.89 $6,020 - $11,154
-5,902 Reduced 10.26%
51,598 $89,000
Q1 2023

May 09, 2023

BUY
$1.0 - $1.35 $10,210 - $13,783
10,210 Added 21.59%
57,500 $62,000
Q4 2022

Feb 14, 2023

BUY
$0.87 - $1.33 $463 - $708
533 Added 1.14%
47,290 $51,000
Q3 2022

Nov 18, 2022

SELL
$1.02 - $1.26 $3,975 - $4,911
-3,898 Reduced 7.7%
46,757 $57,000
Q2 2022

Aug 15, 2022

BUY
$0.91 - $2.01 $1,686 - $3,724
1,853 Added 3.8%
50,655 $52,000
Q1 2022

May 16, 2022

SELL
$1.22 - $2.03 $2,225 - $3,702
-1,824 Reduced 3.6%
48,802 $87,000
Q4 2021

Feb 15, 2022

BUY
$1.27 - $2.23 $4,494 - $7,891
3,539 Added 7.52%
50,626 $69,000
Q3 2021

Nov 15, 2021

SELL
$2.12 - $2.76 $157,198 - $204,653
-74,150 Reduced 61.16%
47,087 $102,000
Q2 2021

Aug 16, 2021

BUY
$1.78 - $2.76 $215,801 - $334,614
121,237 New
121,237 $302,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.6B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.